Jon Wilson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jon Wilson has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
- Brioney Gee
Norfolk and Suffolk NHS Foundation Trust
8 shared publications - Caitlin Notley
Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norwich, UK
7 shared publications - Bonnie Teague
Norfolk and Suffolk NHS Foundation Trust
5 shared publications - David Fowler
School of Psychology, University of Sussex, Brighton, UK
5 shared publications - Tim Clarke
Research and Development, Norfolk and Suffolk NHS Foundation Trust, Norwich, UK
5 shared publications - Joanne Hodgekins
Norwich Medical School, University of East Anglia, Norwich, UK
4 shared publications
Latest Publications
- Open Access
- 11 July 2026
- Published by Elsevier in SSRN Electronic Journal
Psychometric evaluation of the C-MABQ15: A theory and evidence-based diagnostic tool to identify medication non-adherence and person-specific determinants in severe mental illness
Background: Medication non-adherence in mental health is a serious issue. A key challenge is identifying person-specific determinants to tailor support. However, comprehensive, theory and evidence-based tools for this purpose are lacking. To address this gap, we developed the 15-item ‘Collaborative Medication Adherence in Bipolar disorder Questionnaire (C-MABQ15)’ underpinned by the Theoretical Domains Framework.Aim: To validate CMAB-Q15 to identify non-adherence and person-specific determinants requiring intervention. Objectives were to: (1) retain items meeting Mokken Scale double monotonicity criteria from initial 50-item C-MABQ (2) evaluate the resulting scale’s psychometric properties.Methods: A cross-section of patients (>18years) in a community mental health setting in England prescribed lithium were invited to complete the initial 50-items C-MABQ; a subsample provided test-retest data. Mokken scale analysis was performed to select unidimensional, locally independent, monotonous and non-intersecting items. Criterion validity was evaluated against the Medication Adherence Report Scale-5 (MARS-5) and blood lithium levels. We assessed readability, model fit, internal consistency (Cronbach’s alpha, α), and test-retest reliability (intra-class correlation coefficient, ICC).Results: Of 835 patients invited, 363 (43.5%) responded; 325 provided complete data. Fifteen items (C-MABQ15) fulfilled Mokken scale criteria demonstrating construct validity. C-MABQ15 showed criterion validity with MARS-5 (r=0.32, p<0.001). C-MABQ15 scores trended as expected with lithium levels; however, between-group difference was non-significant (mean difference -0.45; p=0.75). C-MABQ15 demonstrated excellent internal consistency (α =0.91, 95% CI=0.89 to 0.93) and good readability, model fit (CFI=0.997, TLI=0.996, RMSEA=0.059), and test-retest reliability (ICC=0.74, 95% CI=0.61 to 0.82, p<0.001).Conclusion: C-MABQ15 identifies non-adherence and person-specific determinants, providing foundation for personalised support.
- 11 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessPsychometric evaluation of the C-MABQ15: A theory and evidence-based diagnostic tool to identify medication non-adherence and person-specific determinants in severe mental illness
Background: Medication non-adherence in mental health is a serious issue. A key challenge is identifying person-specific determinants to tailor support. However, comprehensive, theory and evidence-based tools for this purpose are lacking. To address this gap, we developed the 15-item ‘Collaborative Medication Adherence in Bipolar disorder Questionnaire (C-MABQ15)’ underpinned by the Theoretical Domains Framework.Aim: To validate CMAB-Q15 to identify non-adherence and person-specific determinants requiring intervention. Objectives were to: (1) retain items meeting Mokken Scale double monotonicity criteria from initial 50-item C-MABQ (2) evaluate the resulting scale’s psychometric properties.Methods: A cross-section of patients (>18years) in a community mental health setting in England prescribed lithium were invited to complete the initial 50-items C-MABQ; a subsample provided test-retest data. Mokken scale analysis was performed to select unidimensional, locally independent, monotonous and non-intersecting items. Criterion validity was evaluated against the Medication Adherence Report Scale-5 (MARS-5) and blood lithium levels. We assessed readability, model fit, internal consistency (Cronbach’s alpha, α), and test-retest reliability (intra-class correlation coefficient, ICC).Results: Of 835 patients invited, 363 (43.5%) responded; 325 provided complete data. Fifteen items (C-MABQ15) fulfilled Mokken scale criteria demonstrating construct validity. C-MABQ15 showed criterion validity with MARS-5 (r=0.32, p<0.001). C-MABQ15 scores trended as expected with lithium levels; however, between-group difference was non-significant (mean difference -0.45; p=0.75). C-MABQ15 demonstrated excellent internal consistency (α =0.91, 95% CI=0.89 to 0.93) and good readability, model fit (CFI=0.997, TLI=0.996, RMSEA=0.059), and test-retest reliability (ICC=0.74, 95% CI=0.61 to 0.82, p<0.001).Conclusion: C-MABQ15 identifies non-adherence and person-specific determinants, providing foundation for personalised support.
- 29 September 2025
- Published by Taylor & Francis in Emotional and Behavioural Difficulties
- Vol. 31 (1) , 93-109
Evaluating the implementation of a novel approach to increasing access to evidence-based treatment for child anxiety difficulties through enhancing collaboration between the health and education systems
- 29 September 2025
- Published by Taylor & Francis in Emotional and Behavioural Difficulties
- Vol. 31 (1) , 93-109
Evaluating the implementation of a novel approach to increasing access to evidence-based treatment for child anxiety difficulties through enhancing collaboration between the health and education systems
- Open Access
- 1 December 2024
- Published by National Institute for Health and Care Research in Health and Social Care Delivery Research
- Vol. 12 (48) , 1-121
Interpersonal counselling for adolescent depression delivered by youth mental health workers without core professional training: the ICALM feasibility RCT
Background: As milder cases of adolescent depression do not meet treatment thresholds for specialist mental health services, young people often receive support from non-qualified professionals in third-sector/voluntary agencies. Early psychological interventions to meet growing demand with limited resources are crucial. Objectives: The study aimed to explore the effectiveness and cost effectiveness of interpersonal counselling for adolescents by (1) assessing the feasibility and acceptability of trial procedures; (2) exploring the delivery of, and differences between, interpersonal counselling for adolescents and treatment as usual; (3) evaluating the extent of contamination of the control arm and if it should be mitigated against in a future trial; and (4) investigating whether the interval estimate of benefit of interpersonal counselling for adolescents over treatment as usual in depression post treatment includes a clinically significant effect. Design: This was a feasibility randomised controlled trial. Non-qualified professionals from non-specialist mental health services received interpersonal counselling for adolescent training. Participants were randomised to receive either interpersonal counselling for adolescents plus treatment as usual or treatment as usual only. Assessments occurred at baseline and were followed up at weeks 5, 10 and 23. A health economics component was included to inform the design of the economic evaluation in a future study. A process evaluation examined implementation of the intervention across settings, acceptability and contamination. Interviews, observations and focus groups were analysed using thematic analysis. Session recordings were analysed using conversation analysis. Setting: The trial was conducted in 13 non-speicialist mental health services across Norfolk and Suffolk. Participants: Help-seeking adolescents aged 12–18 years with mild depression as the primary difficulty were eligible to participate. Comorbid presentations were not an exclusion criterion. Of a target of 60, 16 participants were randomised, and 2 participants withdrew following study suspensions related to COVID-19. Of the remaining 14 participants, 7 received an intervention, with 3 receiving interpersonal counselling for adolescents and 4 receiving treatment as usual. The rest either disengaged, withdrew or were signposted. Interventions: Participants were randomised to receive either interpersonal counselling for adolescents plus treatment as usual or treatment as usual only. Main outcome measures: The primary outcome was the Revised Children’s Anxiety and Depression Scale, although the proposed study was not designed to assess efficacy. The primary output of the feasibility trial was to design a subsequent full-scale trial. Results: Feasibility outcomes did not meet the estimated progression criteria. Despite efforts to increase referrals, the 80% recruitment rate was not achieved. Interpersonal counselling for adolescents' attendance rates at 10 weeks were less than the 70% progression criteria estimation, impacting intervention feasibility. Retention was high, with 85.7% of participants reaching 23-week follow-up. The health economic measures appeared to perform well and were completed. Implementation and theoretical fidelity of interpersonal counselling for adolescents were analysed from four participant recordings. Adherence to the principles of interpersonal counselling for adolescents was identified, with 100% satisfactory fidelity and no indication of contamination in the control arm. The two interventions were clinically non-significant due to the study being underpowered. Limitations: The feasibility of the randomised controlled trial was impacted by COVID-19. Services had to change standard practices, disrupting trial procedures. Challenges were identified when implementing a randomised controlled trial in non-specialist services. Conclusions: Findings indicate a randomised controlled trial of interpersonal counselling for adolescents in non-specialist services is not feasible, yet the data collection and outcome measures were suitable. COVID-19 challenges, sites’ lack of familiarity with research procedures and the research team’s unfamiliarity with how different early intervention services operate led to challenges. High staff shortages, turnover and inconsistent training could have been considered. This study demonstrated the difficulties in conducting a randomised controlled trial in this service setting. Further work is needed to improve the feasibility of conducting such trials before they are attempted in future. Trial registration: This trial is registered as ISRCTN82180413. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme (NIHR award ref: 17/112/16) and is published in full in Health and Social Care Delivery Research; Vol. 12, No. 48. See the NIHR Funding and Awards website for further award information.
- 1 December 2024
- Published by National Institute for Health and Care Research in Health and Social Care Delivery Research
- Vol. 12 (48) , 1-121
Open AccessInterpersonal counselling for adolescent depression delivered by youth mental health workers without core professional training: the ICALM feasibility RCT
Background: As milder cases of adolescent depression do not meet treatment thresholds for specialist mental health services, young people often receive support from non-qualified professionals in third-sector/voluntary agencies. Early psychological interventions to meet growing demand with limited resources are crucial. Objectives: The study aimed to explore the effectiveness and cost effectiveness of interpersonal counselling for adolescents by (1) assessing the feasibility and acceptability of trial procedures; (2) exploring the delivery of, and differences between, interpersonal counselling for adolescents and treatment as usual; (3) evaluating the extent of contamination of the control arm and if it should be mitigated against in a future trial; and (4) investigating whether the interval estimate of benefit of interpersonal counselling for adolescents over treatment as usual in depression post treatment includes a clinically significant effect. Design: This was a feasibility randomised controlled trial. Non-qualified professionals from non-specialist mental health services received interpersonal counselling for adolescent training. Participants were randomised to receive either interpersonal counselling for adolescents plus treatment as usual or treatment as usual only. Assessments occurred at baseline and were followed up at weeks 5, 10 and 23. A health economics component was included to inform the design of the economic evaluation in a future study. A process evaluation examined implementation of the intervention across settings, acceptability and contamination. Interviews, observations and focus groups were analysed using thematic analysis. Session recordings were analysed using conversation analysis. Setting: The trial was conducted in 13 non-speicialist mental health services across Norfolk and Suffolk. Participants: Help-seeking adolescents aged 12–18 years with mild depression as the primary difficulty were eligible to participate. Comorbid presentations were not an exclusion criterion. Of a target of 60, 16 participants were randomised, and 2 participants withdrew following study suspensions related to COVID-19. Of the remaining 14 participants, 7 received an intervention, with 3 receiving interpersonal counselling for adolescents and 4 receiving treatment as usual. The rest either disengaged, withdrew or were signposted. Interventions: Participants were randomised to receive either interpersonal counselling for adolescents plus treatment as usual or treatment as usual only. Main outcome measures: The primary outcome was the Revised Children’s Anxiety and Depression Scale, although the proposed study was not designed to assess efficacy. The primary output of the feasibility trial was to design a subsequent full-scale trial. Results: Feasibility outcomes did not meet the estimated progression criteria. Despite efforts to increase referrals, the 80% recruitment rate was not achieved. Interpersonal counselling for adolescents' attendance rates at 10 weeks were less than the 70% progression criteria estimation, impacting intervention feasibility. Retention was high, with 85.7% of participants reaching 23-week follow-up. The health economic measures appeared to perform well and were completed. Implementation and theoretical fidelity of interpersonal counselling for adolescents were analysed from four participant recordings. Adherence to the principles of interpersonal counselling for adolescents was identified, with 100% satisfactory fidelity and no indication of contamination in the control arm. The two interventions were clinically non-significant due to the study being underpowered. Limitations: The feasibility of the randomised controlled trial was impacted by COVID-19. Services had to change standard practices, disrupting trial procedures. Challenges were identified when implementing a randomised controlled trial in non-specialist services. Conclusions: Findings indicate a randomised controlled trial of interpersonal counselling for adolescents in non-specialist services is not feasible, yet the data collection and outcome measures were suitable. COVID-19 challenges, sites’ lack of familiarity with research procedures and the research team’s unfamiliarity with how different early intervention services operate led to challenges. High staff shortages, turnover and inconsistent training could have been considered. This study demonstrated the difficulties in conducting a randomised controlled trial in this service setting. Further work is needed to improve the feasibility of conducting such trials before they are attempted in future. Trial registration: This trial is registered as ISRCTN82180413. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme (NIHR award ref: 17/112/16) and is published in full in Health and Social Care Delivery Research; Vol. 12, No. 48. See the NIHR Funding and Awards website for further award information.
- Open Access
- 22 October 2024
- Published by JMIR Publications Inc. in JMIR Mental Health
- Vol. 11 (1) , e52866
Outcomes of Providing Children Aged 7-12 Years With Access to Evidence-Based Anxiety Treatment Via a Standalone Digital Intervention Using Immersive Gaming Technology: Real-World Evaluation
Background: Anxiety disorders are among the most common mental health conditions in childhood, but most children with anxiety disorders do not access evidence-based interventions. The delivery of therapeutic interventions via digital technologies has been proposed to significantly increase timely access to evidence-based treatment. Lumi Nova (BfB Labs Limited) is a digital therapeutic intervention designed to deliver evidence-based anxiety treatment for those aged 7‐12 years through a mobile app incorporating immersive gaming technology. Objective: We aimed to evaluate the real-world impact of providing access to Lumi Nova through UK National Health Service–funded mental health services. Methods: We analyzed precollected anonymized data routinely captured through the implementation of Lumi Nova from children aged 7‐12 years, who lived in the United Kingdom and had the opportunity to use the intervention for at least 1 week over an 18-month period. Engagement indices included whether the game key was activated, number of unique sessions, time spent engaging, and number of “challenges” completed. Clinical outcomes were assessed using the Goal-Based Outcomes measure and Child Outcome Rating Scale. Demographic data were analyzed to assess the health equality implications of Lumi Nova. Results: Of 1029 eligible families invited to use Lumi Nova, 644 (62.5%) activated their game key, of whom 374 (58.1%) completed at least one in-game graded exposure challenge. The median number of unique sessions was 6 (IQR 3‐12) and the median time spent engaging with the intervention was 42 (IQR 15‐79) minutes. For the subset of young people with paired outcomes, there were statistically significant small to medium improvements in goal-based outcome scores (n=224; t223=5.78, P<.001; d=0.37, 95% CI 0.25‐0.52) and Child Outcome Rating Scale scores (n=123; t122=5.10, P<.001; d=0.46, 95% CI 0.27‐0.65) between the first and last data points. Two in 5 young people’s scores reflected a change that would be considered reliable. Analysis of demographic characteristics tentatively suggested that children from ethnic minority backgrounds and those living in the most deprived neighbourhoods may be less likely to access Lumi Nova, but children from socioeconomically deprived areas were more likely to successfully complete a challenge once they accessed the intervention (P=.02). However, the level of missing data and small number of children in some demographic groups limited meaningful statistical comparisons. Conclusions: This study provides initial evidence that Lumi Nova may be associated with improved outcomes for those aged 7‐12 years seeking anxiety treatment in real-world settings. However, the lack of a control comparator group and information about concurrent treatments accessed by the young people, in addition to substantial attrition, limited the analysis that could be conducted and confidence in the conclusions drawn.
- 22 October 2024
- Published by JMIR Publications Inc. in JMIR Mental Health
- Vol. 11 (1) , e52866
Open AccessOutcomes of Providing Children Aged 7-12 Years With Access to Evidence-Based Anxiety Treatment Via a Standalone Digital Intervention Using Immersive Gaming Technology: Real-World Evaluation
Background: Anxiety disorders are among the most common mental health conditions in childhood, but most children with anxiety disorders do not access evidence-based interventions. The delivery of therapeutic interventions via digital technologies has been proposed to significantly increase timely access to evidence-based treatment. Lumi Nova (BfB Labs Limited) is a digital therapeutic intervention designed to deliver evidence-based anxiety treatment for those aged 7‐12 years through a mobile app incorporating immersive gaming technology. Objective: We aimed to evaluate the real-world impact of providing access to Lumi Nova through UK National Health Service–funded mental health services. Methods: We analyzed precollected anonymized data routinely captured through the implementation of Lumi Nova from children aged 7‐12 years, who lived in the United Kingdom and had the opportunity to use the intervention for at least 1 week over an 18-month period. Engagement indices included whether the game key was activated, number of unique sessions, time spent engaging, and number of “challenges” completed. Clinical outcomes were assessed using the Goal-Based Outcomes measure and Child Outcome Rating Scale. Demographic data were analyzed to assess the health equality implications of Lumi Nova. Results: Of 1029 eligible families invited to use Lumi Nova, 644 (62.5%) activated their game key, of whom 374 (58.1%) completed at least one in-game graded exposure challenge. The median number of unique sessions was 6 (IQR 3‐12) and the median time spent engaging with the intervention was 42 (IQR 15‐79) minutes. For the subset of young people with paired outcomes, there were statistically significant small to medium improvements in goal-based outcome scores (n=224; t223=5.78, P<.001; d=0.37, 95% CI 0.25‐0.52) and Child Outcome Rating Scale scores (n=123; t122=5.10, P<.001; d=0.46, 95% CI 0.27‐0.65) between the first and last data points. Two in 5 young people’s scores reflected a change that would be considered reliable. Analysis of demographic characteristics tentatively suggested that children from ethnic minority backgrounds and those living in the most deprived neighbourhoods may be less likely to access Lumi Nova, but children from socioeconomically deprived areas were more likely to successfully complete a challenge once they accessed the intervention (P=.02). However, the level of missing data and small number of children in some demographic groups limited meaningful statistical comparisons. Conclusions: This study provides initial evidence that Lumi Nova may be associated with improved outcomes for those aged 7‐12 years seeking anxiety treatment in real-world settings. However, the lack of a control comparator group and information about concurrent treatments accessed by the young people, in addition to substantial attrition, limited the analysis that could be conducted and confidence in the conclusions drawn.
- Open Access
- 1 August 2024
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e64947
Exploring the use of digital technology to support health behaviour change in young people under the care of a Complications of Excess Weight service: a qualitative patient-centred design study (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The increasing prevalence of paediatric obesity presents a major challenge for healthcare services. In England, Complications of Excess Weight (CEW) clinics provide specialist multidisciplinary care for children presenting with co-morbidities of severe obesity. Positive treatment outcomes require the young person and their family to make behavioural changes to improve the child’s health. However, there are many barriers to health behaviour change, particularly for adolescents. Digital technology could be used to enhance the support offered by CEW clinics to adolescent patients to increase the likelihood of successful behavioural change, but little is known about their and their families’ views of this. Objective: We aimed to explore the views of adolescent patients and their families on how digital technology could be utilised by CEW clinics to support health behaviour change. Methods: The study took a participatory design approach. Four focus groups and co-design workshops were facilitated by a cross-disciplinary team of clinicians, academics and technology innovators. Participants were adolescent CEW clinic patients (aged 10-16 years) and their adult family members. Focus groups and workshops explored young people’s health priorities, the barriers and facilitators of health behaviour change, and co-designed ways in which technology could be used to support young people in overcoming these barriers to achieve their health goals. Focus group data were analysed using inductive content analysis, with findings integrated with key co-design workshop outputs. Results: 37 individuals (19 adolescents, 18 family members) participated across the focus groups and workshops. Participants were in favour of the increased use of digital technology by CEW clinics as an adjunct to in-person support. Weight was not mentioned by participants as an important aspect of their health. Instead, mental health, sleep and peer support were identified as the domains in which adolescent CEW patients felt they would most benefit from additional support and participants reported that technology could be helpful in providing this support. Participants expressed a preference for technology able to individually tailor content to the young person’s needs, including relatable peer-produced content. The need for support for both the young person themselves and their family members was highlighted, as well as the need to integrate strategies to maintain engagement with any technological offering. Conclusions: There is clear potential for digital technology to be used to support the holistic health priorities of young people receiving specialist care for co-morbidities related to excess weight. We plan to use the findings of this study as the basis to begin developing innovative approaches to the use of technology to support this high-need group.
- 1 August 2024
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e64947
Open AccessExploring the use of digital technology to support health behaviour change in young people under the care of a Complications of Excess Weight service: a qualitative patient-centred design study (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The increasing prevalence of paediatric obesity presents a major challenge for healthcare services. In England, Complications of Excess Weight (CEW) clinics provide specialist multidisciplinary care for children presenting with co-morbidities of severe obesity. Positive treatment outcomes require the young person and their family to make behavioural changes to improve the child’s health. However, there are many barriers to health behaviour change, particularly for adolescents. Digital technology could be used to enhance the support offered by CEW clinics to adolescent patients to increase the likelihood of successful behavioural change, but little is known about their and their families’ views of this. Objective: We aimed to explore the views of adolescent patients and their families on how digital technology could be utilised by CEW clinics to support health behaviour change. Methods: The study took a participatory design approach. Four focus groups and co-design workshops were facilitated by a cross-disciplinary team of clinicians, academics and technology innovators. Participants were adolescent CEW clinic patients (aged 10-16 years) and their adult family members. Focus groups and workshops explored young people’s health priorities, the barriers and facilitators of health behaviour change, and co-designed ways in which technology could be used to support young people in overcoming these barriers to achieve their health goals. Focus group data were analysed using inductive content analysis, with findings integrated with key co-design workshop outputs. Results: 37 individuals (19 adolescents, 18 family members) participated across the focus groups and workshops. Participants were in favour of the increased use of digital technology by CEW clinics as an adjunct to in-person support. Weight was not mentioned by participants as an important aspect of their health. Instead, mental health, sleep and peer support were identified as the domains in which adolescent CEW patients felt they would most benefit from additional support and participants reported that technology could be helpful in providing this support. Participants expressed a preference for technology able to individually tailor content to the young person’s needs, including relatable peer-produced content. The need for support for both the young person themselves and their family members was highlighted, as well as the need to integrate strategies to maintain engagement with any technological offering. Conclusions: There is clear potential for digital technology to be used to support the holistic health priorities of young people receiving specialist care for co-morbidities related to excess weight. We plan to use the findings of this study as the basis to begin developing innovative approaches to the use of technology to support this high-need group.
- Open Access
- 17 February 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (4) , 3539
Predictors of Post-Traumatic Growth in a Sample of United Kingdom Mental and Community Healthcare Workers during the COVID-19 Pandemic
Experiences of adversity can generate positive psychological effects alongside negative impacts. Little research to date has evaluated predictors of post-traumatic growth in mental or community healthcare workers during the COVID-19 pandemic. Following a survey of 854 community and mental healthcare staff in the United Kingdom in July to September 2020, multiple linear regression was used to determine the association between hypothesised risk and protective factors (personal, organisational and environmental variables) and total scores on the Post-traumatic Growth Inventory–Short Version. Positive self-reflection activities, black and minority ethnic status, developing new healthcare knowledge and skills, connecting with friends and family, feeling supported by senior management, feeling supported by the UK people, and anxiety about the personal and work-related consequences of COVID-19 each significantly independently predicted greater post-traumatic growth. Working in a clinical role and in mental healthcare or community physical healthcare predicted lower post-traumatic growth. Our research supports the value of taking an organisational growth-focused approach to occupational health during times of adversity, by supporting staff to embrace opportunities for personal growth. Valuing staff’s cultural and religious identity and encouraging self-reflective activities, such as mindfulness and meditation, may help to promote post-traumatic growth.
- 17 February 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (4) , 3539
Open AccessPredictors of Post-Traumatic Growth in a Sample of United Kingdom Mental and Community Healthcare Workers during the COVID-19 Pandemic
Experiences of adversity can generate positive psychological effects alongside negative impacts. Little research to date has evaluated predictors of post-traumatic growth in mental or community healthcare workers during the COVID-19 pandemic. Following a survey of 854 community and mental healthcare staff in the United Kingdom in July to September 2020, multiple linear regression was used to determine the association between hypothesised risk and protective factors (personal, organisational and environmental variables) and total scores on the Post-traumatic Growth Inventory–Short Version. Positive self-reflection activities, black and minority ethnic status, developing new healthcare knowledge and skills, connecting with friends and family, feeling supported by senior management, feeling supported by the UK people, and anxiety about the personal and work-related consequences of COVID-19 each significantly independently predicted greater post-traumatic growth. Working in a clinical role and in mental healthcare or community physical healthcare predicted lower post-traumatic growth. Our research supports the value of taking an organisational growth-focused approach to occupational health during times of adversity, by supporting staff to embrace opportunities for personal growth. Valuing staff’s cultural and religious identity and encouraging self-reflective activities, such as mindfulness and meditation, may help to promote post-traumatic growth.
- Open Access
- 1 December 2022
- Published by National Institute for Health and Care Research in Health and Social Care Delivery Research
- Vol. 10 (37) , 1-112
Brief education supported psychological treatment for adolescent borderline personality disorder: the BEST feasibility RCT
Background: Borderline personality disorder is a severe mental health condition characterised by a pattern of emotional instability, interpersonal dysfunction, disturbed self-image and impulsive behaviour, including self-harm. Symptoms of borderline personality disorder typically emerge during adolescence. Although there is compelling evidence in support of early intervention for borderline personality disorder, current evidence-based interventions are resource intensive, with the result that few young people access timely treatment. Therefore, there is an urgent need for accessible interventions to facilitate early intervention for adolescents with borderline personality disorder symptoms.Objectives: The first objective was to adapt a brief psychological treatment for adolescent borderline personality disorder that had previously been delivered within secondary mental health services for co-delivery within schools and colleges. The second objective was to assess the feasibility of evaluating the clinical effectiveness and cost-effectiveness of this intervention in a future randomised controlled trial.Design: We first conducted a rapid evidence synthesis of barriers to and facilitators of the implementation of indicated mental health interventions for adolescents within educational settings and piloted the prototype intervention with three schools/colleges. Based on the findings of the evidence synthesis and pilot, we refined the intervention and study procedures in preparation for a feasibility randomised controlled trial. The feasibility randomised controlled trial involved 12 schools and colleges, whose pastoral staff members received training to deliver the intervention alongside a mental health practitioner. Participants were randomised in a 1 : 1 ratio to receive either the BEST (Brief Education Supported Treatment) intervention plus treatment as usual or treatment as usual alone. Participants were assessed pre randomisation (baseline) and at 12 and 24 weeks post randomisation. Mixed-methods process data were collected to understand how the intervention was implemented, to assess acceptability and to monitor contamination of the control arm.Participants: Young people eligible to participate were aged 13–18 years, reported symptoms of borderline personality disorder above an established threshold and had a history of repeated self-harm.Results: The intervention was refined based on findings of the rapid evidence synthesis, which included 50 studies, feedback from staff participants in the pilot and analysis of session recordings. In the feasibility randomised controlled trial, we randomised 32 participants prior to the premature closure of recruitment. The rate of recruitment was slower than anticipated but would probably have narrowly surpassed our progression criterion over the full recruitment window. Participant retention was high (89.5% at 12 weeks and 73.7% at 24 weeks) and the performance of the proposed outcome measures was satisfactory. We did not find any evidence that participants allocated to the treatment-as-usual arm received the BEST intervention or its components. Fidelity of intervention delivery was high (93.5% of recordings rated as adherent) and the intervention was viewed as offering benefits for individual participants, practitioners involved in co-delivery and the wider school/college.Limitations: The feasibility randomised controlled trial was disrupted by the closure of schools and colleges in response to the COVID-19 pandemic. This reduced the window for participant recruitment and limited the data that could be collected.Conclusions: The refined BEST intervention was able to be delivered successfully within schools and colleges and was found to be acceptable to staff and young people. The findings provide support for continuing this programme of research and would inform the design of a future trial.Trial registration: This trial is registered as ISRCTN16862589.Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme and will be published in full inHealth and Social Care Delivery Research; Vol. 10, No. 37. See the NIHR Journals Library website for further project information.
- 1 December 2022
- Published by National Institute for Health and Care Research in Health and Social Care Delivery Research
- Vol. 10 (37) , 1-112
Open AccessBrief education supported psychological treatment for adolescent borderline personality disorder: the BEST feasibility RCT
Background: Borderline personality disorder is a severe mental health condition characterised by a pattern of emotional instability, interpersonal dysfunction, disturbed self-image and impulsive behaviour, including self-harm. Symptoms of borderline personality disorder typically emerge during adolescence. Although there is compelling evidence in support of early intervention for borderline personality disorder, current evidence-based interventions are resource intensive, with the result that few young people access timely treatment. Therefore, there is an urgent need for accessible interventions to facilitate early intervention for adolescents with borderline personality disorder symptoms.Objectives: The first objective was to adapt a brief psychological treatment for adolescent borderline personality disorder that had previously been delivered within secondary mental health services for co-delivery within schools and colleges. The second objective was to assess the feasibility of evaluating the clinical effectiveness and cost-effectiveness of this intervention in a future randomised controlled trial.Design: We first conducted a rapid evidence synthesis of barriers to and facilitators of the implementation of indicated mental health interventions for adolescents within educational settings and piloted the prototype intervention with three schools/colleges. Based on the findings of the evidence synthesis and pilot, we refined the intervention and study procedures in preparation for a feasibility randomised controlled trial. The feasibility randomised controlled trial involved 12 schools and colleges, whose pastoral staff members received training to deliver the intervention alongside a mental health practitioner. Participants were randomised in a 1 : 1 ratio to receive either the BEST (Brief Education Supported Treatment) intervention plus treatment as usual or treatment as usual alone. Participants were assessed pre randomisation (baseline) and at 12 and 24 weeks post randomisation. Mixed-methods process data were collected to understand how the intervention was implemented, to assess acceptability and to monitor contamination of the control arm.Participants: Young people eligible to participate were aged 13–18 years, reported symptoms of borderline personality disorder above an established threshold and had a history of repeated self-harm.Results: The intervention was refined based on findings of the rapid evidence synthesis, which included 50 studies, feedback from staff participants in the pilot and analysis of session recordings. In the feasibility randomised controlled trial, we randomised 32 participants prior to the premature closure of recruitment. The rate of recruitment was slower than anticipated but would probably have narrowly surpassed our progression criterion over the full recruitment window. Participant retention was high (89.5% at 12 weeks and 73.7% at 24 weeks) and the performance of the proposed outcome measures was satisfactory. We did not find any evidence that participants allocated to the treatment-as-usual arm received the BEST intervention or its components. Fidelity of intervention delivery was high (93.5% of recordings rated as adherent) and the intervention was viewed as offering benefits for individual participants, practitioners involved in co-delivery and the wider school/college.Limitations: The feasibility randomised controlled trial was disrupted by the closure of schools and colleges in response to the COVID-19 pandemic. This reduced the window for participant recruitment and limited the data that could be collected.Conclusions: The refined BEST intervention was able to be delivered successfully within schools and colleges and was found to be acceptable to staff and young people. The findings provide support for continuing this programme of research and would inform the design of a future trial.Trial registration: This trial is registered as ISRCTN16862589.Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme and will be published in full inHealth and Social Care Delivery Research; Vol. 10, No. 37. See the NIHR Journals Library website for further project information.
- 24 October 2022
- Published by Emerald Publishing in Journal of Public Mental Health
- Vol. 21 (4) , 303-308
A child and adult psychiatrist discussion on the development of a youth mental health service
Purpose: Young people can often “fall through the gaps” between Child and Adolescent Mental Health services (CAMHS) and Adult Mental Health services (AMHS). This discursive viewpoint study aims to reflect a conversation among the authors on how CAMHS and AMHS psychiatry came together to develop and embed a UK community “Youth Mental Health Service”. Design/methodology/approach: This reflective viewpoint study explores the perspectives of three of the lead CAMHS and AMHS psychiatrists from the implementation phase of a community youth mental health service. It explores, in a discursive way, these individuals’ views on some of the key facilitators and barriers in the development of the service that aimed to “bridge the gap” for young people. Findings: These clinicians’ reflections recognise the importance of strong clinical leadership in enabling a youth/young adult model of mental health to be implemented. They also recognise how culture internal and external to a service has a key role to play in the success and sustainment of implementing an innovative model. This study describes a merging of CAMHS and AMHS psychiatry to meet the needs of young people in the most developmentally appropriate way. Originality/value: This reflective study highlights the need for services and systems to think creatively about how they can allow flexibility for CAMHS and AMHS psychiatrists to learn and plan together, as well as gain experiences across the age ranges, to facilitate collaborative working that is developmentally appropriate and meets the needs of young people in a way that is accessible to them.
- 24 October 2022
- Published by Emerald Publishing in Journal of Public Mental Health
- Vol. 21 (4) , 303-308
A child and adult psychiatrist discussion on the development of a youth mental health service
Purpose: Young people can often “fall through the gaps” between Child and Adolescent Mental Health services (CAMHS) and Adult Mental Health services (AMHS). This discursive viewpoint study aims to reflect a conversation among the authors on how CAMHS and AMHS psychiatry came together to develop and embed a UK community “Youth Mental Health Service”. Design/methodology/approach: This reflective viewpoint study explores the perspectives of three of the lead CAMHS and AMHS psychiatrists from the implementation phase of a community youth mental health service. It explores, in a discursive way, these individuals’ views on some of the key facilitators and barriers in the development of the service that aimed to “bridge the gap” for young people. Findings: These clinicians’ reflections recognise the importance of strong clinical leadership in enabling a youth/young adult model of mental health to be implemented. They also recognise how culture internal and external to a service has a key role to play in the success and sustainment of implementing an innovative model. This study describes a merging of CAMHS and AMHS psychiatry to meet the needs of young people in the most developmentally appropriate way. Originality/value: This reflective study highlights the need for services and systems to think creatively about how they can allow flexibility for CAMHS and AMHS psychiatrists to learn and plan together, as well as gain experiences across the age ranges, to facilitate collaborative working that is developmentally appropriate and meets the needs of young people in a way that is accessible to them.
- 1 October 2022
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 26 (42) , 1-174
One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT
Background: Up to 10% of children and young people have a specific phobia that can significantly affect their mental health, development and daily functioning. Cognitive–behavioural therapy-based interventions remain the dominant treatment, but limitations to their provision warrant investigation into low-intensity alternatives. One-session treatment is one such alternative that shares cognitive–behavioural therapy principles but has a shorter treatment period.Objective: This research investigated the non-inferiority of one-session treatment to cognitive–behavioural therapy for treating specific phobias in children and young people. The acceptability and cost-effectiveness of one-session treatment were examined.Design: A pragmatic, multicentre, non-inferiority randomised controlled trial, with embedded economic and qualitative evaluations.Settings: There were 26 sites, including 12 NHS trusts.Participants: Participants were aged 7–16 years and had a specific phobia defined in accordance with established international clinical criteria.Interventions: Participants were randomised 1 : 1 to receive one-session treatment or usual-care cognitive–behavioural therapy, and were stratified according to age and phobia severity. Outcome assessors remained blind to treatment allocation.Main outcome measures: The primary outcome measure was the Behavioural Avoidance Task at 6 months’ follow-up. Secondary outcomes included the Anxiety Disorder Interview Schedule, Child Anxiety Impact Scale, Revised Children’s Anxiety and Depression Scale, a goal-based outcome measure, Child Health Utility 9D, EuroQol-5 Dimensions Youth version and resource usage. Treatment fidelity was assessed using the Cognitive Behaviour Therapy Scale for Children and Young People and the One-Session Treatment Rating Scale.Results: A total of 274 participants were recruited, with 268 participants randomised to one-session treatment (n = 134) or cognitive–behavioural therapy (n = 134). A total of 197 participants contributed some data, with 149 participants in the intention-to-treat analysis and 113 in the per-protocol analysis. Mean Behavioural Avoidance Task scores at 6 months were similar across treatment groups when both intention-to-treat and per-protocol analyses were applied [cognitive–behavioural therapy: 7.1 (intention to treat), 7.4 (per protocol); one-session treatment: 7.4 (intention to treat), 7.6 (per protocol); on the standardised scale adjusted mean difference for cognitive–behavioural therapy compared with one-session treatment –0.123, 95% confidence interval –0.449 to 0.202 (intention to treat), mean difference –0.204, 95% confidence interval –0.579 to 0.171 (per protocol)]. These findings were wholly below the standardised non-inferiority limit of 0.4, which suggests that one-session treatment is non-inferior to cognitive–behavioural therapy. No between-group differences in secondary outcome measures were found. The health economics evaluation suggested that, compared with cognitive–behavioural therapy, one-session treatment marginally decreased the mean service use costs and maintained similar mean quality-adjusted life-year improvement. Nested qualitative evaluation found one-session treatment to be considered acceptable by those who received it, their parents/guardians and clinicians. No adverse events occurred as a result of phobia treatment.Limitations: The COVID-19 pandemic meant that 48 children and young people could not complete the primary outcome measure. Service waiting times resulted in some participants not starting therapy before follow-up.Conclusions: One-session treatment for specific phobia in UK-based child mental health treatment centres is as clinically effective as multisession cognitive–behavioural therapy and highly likely to be cost-saving. Future work could involve improving the implementation of one-session treatment through training and commissioning of improved care pathways.Trial registration: This trial is registered as ISRCTN19883421.Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full inHealth Technology Assessment; Vol. 26, No. 42. See the NIHR Journals Library website for further project information.
- 1 October 2022
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 26 (42) , 1-174
One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT
Background: Up to 10% of children and young people have a specific phobia that can significantly affect their mental health, development and daily functioning. Cognitive–behavioural therapy-based interventions remain the dominant treatment, but limitations to their provision warrant investigation into low-intensity alternatives. One-session treatment is one such alternative that shares cognitive–behavioural therapy principles but has a shorter treatment period.Objective: This research investigated the non-inferiority of one-session treatment to cognitive–behavioural therapy for treating specific phobias in children and young people. The acceptability and cost-effectiveness of one-session treatment were examined.Design: A pragmatic, multicentre, non-inferiority randomised controlled trial, with embedded economic and qualitative evaluations.Settings: There were 26 sites, including 12 NHS trusts.Participants: Participants were aged 7–16 years and had a specific phobia defined in accordance with established international clinical criteria.Interventions: Participants were randomised 1 : 1 to receive one-session treatment or usual-care cognitive–behavioural therapy, and were stratified according to age and phobia severity. Outcome assessors remained blind to treatment allocation.Main outcome measures: The primary outcome measure was the Behavioural Avoidance Task at 6 months’ follow-up. Secondary outcomes included the Anxiety Disorder Interview Schedule, Child Anxiety Impact Scale, Revised Children’s Anxiety and Depression Scale, a goal-based outcome measure, Child Health Utility 9D, EuroQol-5 Dimensions Youth version and resource usage. Treatment fidelity was assessed using the Cognitive Behaviour Therapy Scale for Children and Young People and the One-Session Treatment Rating Scale.Results: A total of 274 participants were recruited, with 268 participants randomised to one-session treatment (n = 134) or cognitive–behavioural therapy (n = 134). A total of 197 participants contributed some data, with 149 participants in the intention-to-treat analysis and 113 in the per-protocol analysis. Mean Behavioural Avoidance Task scores at 6 months were similar across treatment groups when both intention-to-treat and per-protocol analyses were applied [cognitive–behavioural therapy: 7.1 (intention to treat), 7.4 (per protocol); one-session treatment: 7.4 (intention to treat), 7.6 (per protocol); on the standardised scale adjusted mean difference for cognitive–behavioural therapy compared with one-session treatment –0.123, 95% confidence interval –0.449 to 0.202 (intention to treat), mean difference –0.204, 95% confidence interval –0.579 to 0.171 (per protocol)]. These findings were wholly below the standardised non-inferiority limit of 0.4, which suggests that one-session treatment is non-inferior to cognitive–behavioural therapy. No between-group differences in secondary outcome measures were found. The health economics evaluation suggested that, compared with cognitive–behavioural therapy, one-session treatment marginally decreased the mean service use costs and maintained similar mean quality-adjusted life-year improvement. Nested qualitative evaluation found one-session treatment to be considered acceptable by those who received it, their parents/guardians and clinicians. No adverse events occurred as a result of phobia treatment.Limitations: The COVID-19 pandemic meant that 48 children and young people could not complete the primary outcome measure. Service waiting times resulted in some participants not starting therapy before follow-up.Conclusions: One-session treatment for specific phobia in UK-based child mental health treatment centres is as clinically effective as multisession cognitive–behavioural therapy and highly likely to be cost-saving. Future work could involve improving the implementation of one-session treatment through training and commissioning of improved care pathways.Trial registration: This trial is registered as ISRCTN19883421.Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full inHealth Technology Assessment; Vol. 26, No. 42. See the NIHR Journals Library website for further project information.
- Open Access
- 1 August 2022
- Published by Wiley in Journal of Child Psychology and Psychiatry
- Vol. 64 (1) , 39-49
One session treatment (OST) is equivalent to multi‐session cognitive behavioral therapy (CBT) in children with specific phobias (ASPECT): results from a national non‐inferiority randomized controlled trial
Background: 5%–10% children and young people (CYP) experience specific phobias that impact daily functioning. Cognitive Behaviour Therapy (CBT) is recommended but has limitations. One Session Treatment (OST), a briefer alternative incorporating CBT principles, has demonstrated efficacy. The Alleviating Specific Phobias Experienced by Children Trial (ASPECT) investigated the non‐inferiority of OST compared to multi‐session CBT for treating specific phobias in CYP. Methods: ASPECT was a pragmatic, multi‐center, non‐inferiority randomized controlled trial in 26 CAMHS sites, three voluntary agency services, and one university‐based CYP well‐being service. CYP aged 7–16 years with specific phobia were randomized to receive OST or CBT. Clinical non‐inferiority and a nested cost‐effectiveness evaluation was assessed 6‐months post‐randomization using the Behavioural Avoidance Task (BAT). Secondary outcome measures included the Anxiety Disorder Interview Schedule, Child Anxiety Impact Scale, Revised Children's Anxiety Depression Scale, goal‐based outcome measure, and EQ‐5DY and CHU‐9D, collected blind at baseline and six‐months. Results: 268 CYPs were randomized to OST ( n = 134) or CBT ( n = 134). Mean BAT scores at 6 months were similar across groups in both intention‐to‐treat (ITT) and per‐protocol (PP) populations (CBT: 7.1 (ITT, n = 76), 7.4 (PP, n = 57), OST: 7.4 (ITT, n = 73), 7.6 (PP, n = 56), on the standardized scale‐adjusted mean difference for CBT compared to OST ‐0.123, 95% CI −0.449 to 0.202 (ITT), mean difference −0.204, 95% CI −0.579 to 0.171 (PP)). These findings were wholly below the standardized non‐inferiority limit of 0.4, suggesting that OST is non‐inferior to CBT. No between‐group differences were found on secondary outcomes. OST marginally decreased mean service use costs and maintained similar mean Quality Adjusted Life Years compared to CBT. Conclusions: One Session Treatment has similar clinical effectiveness to CBT for specific phobias in CYP and may be a cost‐saving alternative.
- 1 August 2022
- Published by Wiley in Journal of Child Psychology and Psychiatry
- Vol. 64 (1) , 39-49
Open AccessOne session treatment (OST) is equivalent to multi‐session cognitive behavioral therapy (CBT) in children with specific phobias (ASPECT): results from a national non‐inferiority randomized controlled trial
Background: 5%–10% children and young people (CYP) experience specific phobias that impact daily functioning. Cognitive Behaviour Therapy (CBT) is recommended but has limitations. One Session Treatment (OST), a briefer alternative incorporating CBT principles, has demonstrated efficacy. The Alleviating Specific Phobias Experienced by Children Trial (ASPECT) investigated the non‐inferiority of OST compared to multi‐session CBT for treating specific phobias in CYP. Methods: ASPECT was a pragmatic, multi‐center, non‐inferiority randomized controlled trial in 26 CAMHS sites, three voluntary agency services, and one university‐based CYP well‐being service. CYP aged 7–16 years with specific phobia were randomized to receive OST or CBT. Clinical non‐inferiority and a nested cost‐effectiveness evaluation was assessed 6‐months post‐randomization using the Behavioural Avoidance Task (BAT). Secondary outcome measures included the Anxiety Disorder Interview Schedule, Child Anxiety Impact Scale, Revised Children's Anxiety Depression Scale, goal‐based outcome measure, and EQ‐5DY and CHU‐9D, collected blind at baseline and six‐months. Results: 268 CYPs were randomized to OST ( n = 134) or CBT ( n = 134). Mean BAT scores at 6 months were similar across groups in both intention‐to‐treat (ITT) and per‐protocol (PP) populations (CBT: 7.1 (ITT, n = 76), 7.4 (PP, n = 57), OST: 7.4 (ITT, n = 73), 7.6 (PP, n = 56), on the standardized scale‐adjusted mean difference for CBT compared to OST ‐0.123, 95% CI −0.449 to 0.202 (ITT), mean difference −0.204, 95% CI −0.579 to 0.171 (PP)). These findings were wholly below the standardized non‐inferiority limit of 0.4, suggesting that OST is non‐inferior to CBT. No between‐group differences were found on secondary outcomes. OST marginally decreased mean service use costs and maintained similar mean Quality Adjusted Life Years compared to CBT. Conclusions: One Session Treatment has similar clinical effectiveness to CBT for specific phobias in CYP and may be a cost‐saving alternative.